Protective effect of Korean Red Ginseng against glucocorticoid-induced osteoporosis in vitro and in vivo

被引:55
|
作者
Kim, Jinhee [1 ]
Lee, Hyejin [1 ]
Kang, Ki Sung [2 ]
Chun, Kwang-Hoon [3 ]
Hwang, Gwi Seo [1 ,2 ]
机构
[1] Gachon Univ, Coll Korean Med, Lab Cell Differentiat Res, Gyeonggi Do 461701, Seongnam, South Korea
[2] Gachon Univ, Coll Korean Med, Gyeonggi Do 461701, Seongnam, South Korea
[3] Gachon Univ, Coll Pharm, Gachon Inst Pharmaceut Sci, Inchon, South Korea
关键词
dexamethasone; Korean Red Ginseng; osteoblast; osteoporosis; Panax ginseng; PANAX-GINSENG; POTENTIAL MECHANISMS; ENDOTHELIAL-CELLS; INDUCED APOPTOSIS; BONE; OSTEOBLASTS; INHIBITION; PREVENTION; OSTEOCYTES; RATS;
D O I
10.1016/j.jgr.2014.06.001
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Background: Glucocorticoids (GCs) are commonly used in many chemotherapeutic protocols and play an important role in the normal regulation of bone remodeling. However, the prolonged use of GCs results in osteoporosis, which is partially due to apoptosis of osteoblasts and osteocytes. In this study, effects of Korean Red Ginseng (KRG) on GC-treated murine osteoblastic MC3T3-E1 cells and a GC-induced osteoporosis mouse model were investigated. Methods: MC3T3-E1 cells were exposed to dexamethasone (Dex) with or without KRG and cell viability was measured by the 344, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. Real-time polymerase chain reaction was performed to evaluate the apoptotic gene expression; osteogenic gene expression and alkaline phosphatase (ALP) activity were also measured. Western blotting was performed to evaluate the mitogen-activated protein kinase (MAPK) proteins. A GC-induced osteoporosis animal model was used for in vivo study. Results and conclusion: The MU assay revealed that Korean Red Ginseng (KRG) prevents loss of cell viability caused by Dex-induced apoptosis in MC3T3E1 cells. Real-time polymerase chain reaction data showed that groups treated with both Dex and KRG exhibited lower mRNA levels of caspase-3 and -9, whereas the mRNA levels of Bcl2, IAPs, and XIAP increased. Moreover, groups treated with both Dex and KRG demonstrated increased mRNA levels of ALP. RUNX2, and bone morphogenic proteins as well as increased ALP activity in MC3T3-E1 cells, compared to cells treated with Dex only. In addition, KRG increased protein kinase B (AKT) phosphorylation and decreased c-Jun N-terminal kinase (JNK) phosphorylation. Moreover, microcomputed tomography analysis of the femurs showed that GC implantation caused trabecular bone loss. However, a significant reduction of bone loss was observed in the KRG-treated group. These results suggest that the molecular mechanism of KRG in the GC-induced apoptosis may lead to the development of therapeutic strategies to prevent and/or delay osteoporosis. Copyright (C) 2014. The Korean Society of Ginseng. Published by Elsevier. All rights reserved.
引用
收藏
页码:46 / 53
页数:8
相关论文
共 50 条
  • [1] Icariin Protects Against Glucocorticoid-Induced Osteoporosis In Vitro and Prevents Glucocorticoid-Induced Osteocyte Apoptosis In Vivo
    Feng, Rongjie
    Feng, Li
    Yuan, Zenong
    Wang, Dachuan
    Wang, Feng
    Tan, Bingyi
    Han, Shijie
    Li, Tao
    Li, Dong
    Han, Yong
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2013, 67 (01) : 189 - 197
  • [2] Icariin Protects Against Glucocorticoid-Induced Osteoporosis In Vitro and Prevents Glucocorticoid-Induced Osteocyte Apoptosis In Vivo
    Rongjie Feng
    Li Feng
    Zenong Yuan
    Dachuan Wang
    Feng Wang
    Bingyi Tan
    Shijie Han
    Tao Li
    Dong Li
    Yong Han
    Cell Biochemistry and Biophysics, 2013, 67 : 189 - 197
  • [3] Antiosteoporosis and bone protective effect of dieckol against glucocorticoid-induced osteoporosis in rats
    Wang, Hao
    Yang, Leigang
    Chao, Junwei
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [4] Poncirin prevents bone loss in glucocorticoid-induced osteoporosis in vivo and in vitro
    Hyung-Young Yoon
    Ye-Yeon Won
    Yoon-Sok Chung
    Journal of Bone and Mineral Metabolism, 2012, 30 : 509 - 516
  • [5] Poncirin prevents bone loss in glucocorticoid-induced osteoporosis in vivo and in vitro
    Yoon, Hyung-Young
    Won, Ye-Yeon
    Chung, Yoon-Sok
    JOURNAL OF BONE AND MINERAL METABOLISM, 2012, 30 (05) : 509 - 516
  • [6] Effect of Ellipticine in Glucocorticoid-Induced Osteoporosis: In Silico and In Vivo Analyses
    Yan Zhang
    Jing Wang
    Revista Brasileira de Farmacognosia, 2023, 33 : 558 - 567
  • [7] Effect of Ellipticine in Glucocorticoid-Induced Osteoporosis: In Silico and In Vivo Analyses
    Zhang, Yan
    Wang, Jing
    REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY, 2023, 33 (03): : 558 - 567
  • [8] In vitro and in vivo experimental effect of Korean red ginseng on erection
    Choi, YD
    Rha, KH
    Choi, HK
    JOURNAL OF UROLOGY, 1999, 162 (04): : 1508 - 1511
  • [9] Korean Guideline for the Prevention and Treatment of Glucocorticoid-induced Osteoporosis
    Park, So Young
    Gong, Hyun Sik
    Kim, Kyoung Min
    Kim, Dam
    Kim, Hayoung
    Jeon, Chan Hong
    Ju, Ji Hyeon
    Lee, Shin-Seok
    Park, Dong Ah
    Sung, Yoon-Kyoung
    Kim, Sang Wan
    JOURNAL OF RHEUMATIC DISEASES, 2018, 25 (04): : 263 - 295
  • [10] In Vitro and In Vivo Inhibition of Glucocorticoid-induced Osteoporosis by the Hexane Extract of Poncirus trifoliata
    Kim, Bo-Young
    Yoon, Hyung-Young
    Yun, Sun-Il
    Woo, Eun-Rhan
    Song, Nan-Kyu
    Kim, Hyun-Gyu
    Jeong, Seon-Yong
    Chung, Yoon-Sok
    PHYTOTHERAPY RESEARCH, 2011, 25 (07) : 1000 - 1010